Royal London Asset Management
INSM icon

Royal London Asset Management’s Insmed INSM Stock Holding History

Royal London Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.37M Buy
14,498
+5,988
+70% +$921K 0.01% 573
2025
Q4 		$1.48M Buy
+8,510
New +$1.55M ﹤0.01% 589

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royal London Asset Management's INSM Position: Q1 2026 in Review

Royal London Asset Management increased its Insmed (INSM) stake by 70% in Q1 2026, buying an estimated $921K and bringing the position to 14,498 shares worth $2.37M. The position accounts for 0.01% of the portfolio, ranked #573.

Royal London Asset Management first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Royal London Asset Management held 14,498 shares of Insmed worth $2.37M as of Q1 2026.
  • Royal London Asset Management bought 5,988 Insmed shares in Q1 2026, an estimated $921K.
  • Insmed made up 0.01% of Royal London Asset Management's portfolio in Q1 2026, its #573 holding.
  • Royal London Asset Management first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.